基于MRI的肝脏脂肪定量:商业产品是否已到临床应用时机?
本研究评估了商业MRI肝脏脂肪分数(HFF)定量方案的临床适用性,并与Dixon同反相位(IP/OP)成像对比。IP/OP在排除肝铁过载病例后与fAH相关性很强(r=0.88),多梯度回波与波谱定量相关性相似(r=0.87…0.93)且对铁过载不敏感;但两种后处理方案的分割质量与工作流仍需改进。
要点
- IP/OP成像在排除肝铁过载后可用于HFF定量,与病理fAH相关性很强(r=0.88)。
- 多梯度回波与多回波波谱对肝铁过载不敏感,相关性相似(r=0.87…0.93)。
- 商业后处理分割常误纳内脏脂肪、肾组织及大血管,波谱定量对内脏脂肪纳入敏感。
核心结论
- IP/OP成像在排除肝铁过载时可定量HFF,而专用多回波序列与波谱对铁过载无偏倚。
- 商业后处理方案的分割质量与工作流需改进,但均能将MRI肝脏脂肪定量带入临床应用。
- 推荐专科腹部影像机构使用商业肝脏脂肪定量工具。
研究设计与样本
- 以组织病理学脂肪细胞分数(fAH)及肝铁浓度(LIC)增高为参考标准。
- 评估Philips LiverHealth与Siemens LiverLab两种商业后处理方案的肝脏分割质量与整体工作流。
诊断标准与关键数值
- IP/OP成像与fAH相关性很强(r=0.88),但需排除3例LIC增高病例。
- 多梯度回波成像与多回波波谱定量与fAH相关性相似(r=0.87…0.93),且对LIC增高不敏感。
- 后处理分割常规律性纳入内脏脂肪、肾组织及大血管;波谱脂肪定量对内脏脂肪纳入敏感。
临床应用与阅片要点
- 使用IP/OP成像定量HFF前需排除肝铁过载,否则结果可能不可靠。
- 多梯度回波与波谱对铁过载不敏感,适合铁过载风险患者的脂肪定量。
- 商业后处理自动分割需人工核查,避免内脏脂肪、肾组织及大血管误纳影响HFF。
局限性
- 原文指出两种商业后处理方案的分割质量与工作流仍需改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: (1) To assess the clinical applicability of commercially available solutions for MR-based quantification of the hepatic fat fraction (HFF) and (2) to compare their results with clinically established in-phase/oppose-phase (IP/OP) imaging as proposed by Dixon.
METHODS: Twenty-eight patients underwent MRI examinations using multigradient-echo sequences including multi-peak modeling and T2∗ correction, IP/OP imaging and multi-echo spectroscopy with successive HFF evaluation. Histopathological examination yielded the fraction of adipose hepatocytes (fAH) and the presence of increased liver iron concentration (LIC). We correlated HFF with fAH, and assessed concordance correlations among the MR-based methods with the presence of increased LIC as a control parameter. We investigated the liver segmentation quality and overall workflow of the postprocessing solutions (Philips LiverHealth and Siemens LiverLab).
RESULTS: IP/OP imaging yielded a very strong correlation (r=0.88) with fAH when excluding three cases with increased LIC. Multigradient echo imaging and multiecho spectroscopy quantifications yielded similar correlations (r=0.87…0.93) as IP/OP imaging but were insensitive to increased LIC. Visceral fat, kidney tissue and major vessels were included regularly in the segmentation. Spectroscopic fat quantification was sensitive to the inclusion of visceral fat.
CONCLUSIONS: IP/OP imaging allows HFF quantification when ruling out hepatic siderosis, whereas dedicated multi-echo imaging sequences and spectroscopy show no bias for increased iron concentration. The segmentation quality and workflow of both postprocessing solutions need to be improved. Nevertheless, all solutions are able to bring MRI-based hepatic fat quantification into the clinical application. We therefore recommend commercial hepatic fat quantification tools for institutions specialised to abdominal imaging.
引用
- Hupfeld S, Pischel D, Jechorek D, et al. MRI-based fat quantification of the liver: Is it time for commercially available products? Eur J Radiol. 2021. PMID: 34656047. doi:10.1016/j.ejrad.2021.109993
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。